Filing Details
- Accession Number:
- 0001209191-23-058816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 17:09:03
- Reporting Period:
- 2023-11-20
- Accepted Time:
- 2023-12-15 17:09:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1095981 | Plus Therapeutics Inc. | PSTV | Surgical & Medical Instruments & Apparatus (3841) | 330827593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203672 | H Marc Hedrick | C/O Plus Therapeutics Inc. 4200 Marathon Boulevard, Suite 200 Austin TX 78756 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-20 | 2,068 | $1.96 | 170 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reflect inadvertent trades made by the reporting person's custodian without authorization.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.